Takeda Pharmaceutical EPS - Earnings per Share 2010-2024 | TAK

Takeda Pharmaceutical earnings per share (EPS) for the twelve months ending September 30, 2024 was $0.40, a 9.82% decline year-over-year.

  • Takeda Pharmaceutical EPS for the quarter ending September 30, 2024 was $0.00, a 100% decline year-over-year.
  • Takeda Pharmaceutical 2024 annual EPS was $0.32, a 57.83% decline from 2023.
  • Takeda Pharmaceutical 2023 annual EPS was $0.75, a 15.1% increase from 2022.
  • Takeda Pharmaceutical 2022 annual EPS was $0.65, a 42.21% decline from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.

Takeda Pharmaceutical EPS - Earnings per Share 2010-2024 | TAK

  • Takeda Pharmaceutical EPS for the quarter ending September 30, 2024 was $0.00, a 100% decline year-over-year.
  • Takeda Pharmaceutical 2024 annual EPS was $0.32, a 57.83% decline from 2023.
  • Takeda Pharmaceutical 2023 annual EPS was $0.75, a 15.1% increase from 2022.
  • Takeda Pharmaceutical 2022 annual EPS was $0.65, a 42.21% decline from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.